Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Rating) Director John Bradley Schmieder sold 2,500 shares of the business’s stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $175.45, for a total value of $438,625.00. Following the transaction, the director now directly owns 68,976 shares in the company, valued at approximately $12,101,839.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Mesa Laboratories Stock Performance
NASDAQ:MLAB opened at $184.15 on Tuesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.13 and a current ratio of 2.80. Mesa Laboratories, Inc. has a fifty-two week low of $114.21 and a fifty-two week high of $333.42. The company has a market cap of $982.81 million, a price-to-earnings ratio of -242.30 and a beta of 0.60. The stock has a fifty day moving average price of $147.21 and a 200-day moving average price of $180.16.
Mesa Laboratories Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Wednesday, November 30th will be paid a $0.16 dividend. The ex-dividend date is Tuesday, November 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.35%. Mesa Laboratories’s payout ratio is -84.21%.
Institutional Investors Weigh In On Mesa Laboratories
Analyst Upgrades and Downgrades
Several research analysts have weighed in on the company. Evercore ISI boosted their price target on Mesa Laboratories to $166.00 in a research report on Tuesday, November 15th. StockNews.com raised Mesa Laboratories from a “sell” rating to a “hold” rating in a report on Friday, November 4th.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.
- Get a free copy of the StockNews.com research report on Mesa Laboratories (MLAB)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Ardelyx is A Buy After Slip in Early 2022
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.